584 related articles for article (PubMed ID: 25756663)
1. A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form.
Vojta J; Jedlička A; Coufal P; Janečková L
J Pharm Biomed Anal; 2015 May; 109():36-44. PubMed ID: 25756663
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a stability-indicating UPLC method for the determination of olmesartan medoxomil, amlodipine and hydrochlorothiazide degradation impurities in their triple-combination dosage form using factorial design of experiments.
Marisetti VM; Katakam P; Siddhani VK; Katari NK
Biomed Chromatogr; 2021 Nov; 35(11):e5194. PubMed ID: 34110035
[TBL] [Abstract][Full Text] [Related]
3. Synchronized separation of seven medications representing most commonly prescribed antihypertensive classes by using reversed-phase liquid chromatography: Application for analysis in their combined formulations.
Ebeid WM; Elkady EF; El-Zaher AA; El-Bagary RI; Patonay G
J Sep Sci; 2014 Apr; 37(7):748-57. PubMed ID: 24482404
[TBL] [Abstract][Full Text] [Related]
4. Concurrent estimation of amlodipine besylate, hydrochlorothiazide and valsartan by RP-HPLC, HPTLC and UV-spectrophotometry.
Sharma M; Kothari C; Sherikar O; Mehta P
J Chromatogr Sci; 2014 Jan; 52(1):27-35. PubMed ID: 23293040
[TBL] [Abstract][Full Text] [Related]
5. Stability-indicating method for simultaneous estimation of olmesartan medoxomile, amlodipine besylate and hydrochlorothiazide by RP-HPLC in tablet dosage form.
Jain PS; Patel MK; Gorle AP; Chaudhari AJ; Surana SJ
J Chromatogr Sci; 2012 Sep; 50(8):680-7. PubMed ID: 22593253
[TBL] [Abstract][Full Text] [Related]
6. RP-HPLC method for simultaneous estimation of bisoprolol fumarate and hydrochlorothiazide in tablet formulation.
Joshi SJ; Karbhari PA; Bhoir SI; Bindu KS; Das C
J Pharm Biomed Anal; 2010 Jul; 52(3):362-71. PubMed ID: 19926421
[TBL] [Abstract][Full Text] [Related]
7. Stability-indicating UPLC method for determination of Valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms.
Krishnaiah Ch; Reddy AR; Kumar R; Mukkanti K
J Pharm Biomed Anal; 2010 Nov; 53(3):483-9. PubMed ID: 20646890
[TBL] [Abstract][Full Text] [Related]
8. Identification and structure elucidation of a new degradation impurity in the multi-component tablets of amlodipine besylate.
Gibala P; Douša M; Kalužíková A; Tkadlecová M; Štefko M; Kalášek S; Břicháč J
J Pharm Biomed Anal; 2019 Jan; 162():112-116. PubMed ID: 30236818
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of valsartan, amlodipine besylate and hydrochlorothiazide using capillary zone electrophoresis (CZE).
Ebeid W; Salim M; Elkady E; Elzahr A; El-Bagary R; Patonay G
Pharmazie; 2015 Jun; 70(6):368-73. PubMed ID: 26189296
[TBL] [Abstract][Full Text] [Related]
10. High performance liquid chromatographic assay of amlodipine, valsartan and hydrochlorothiazide simultaneously and its application to pharmaceuticals, urine and plasma analysis.
Shaikh JSA; Raut S; Abdul A; Pathan MAAK
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Oct; 1155():122295. PubMed ID: 32771968
[TBL] [Abstract][Full Text] [Related]
11. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
Kumar N; Sangeetha D; Reddy SP
J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
[TBL] [Abstract][Full Text] [Related]
13. A novel stability-indicating UPLC method development and validation for the determination of seven impurities in various diclofenac pharmaceutical dosage forms.
Azougagh M; Elkarbane M; Bakhous K; Issmaili S; Skalli A; Iben Moussad S; Benaji B
Ann Pharm Fr; 2016 Sep; 74(5):358-69. PubMed ID: 27475309
[TBL] [Abstract][Full Text] [Related]
14. A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form.
Sharma N; Rao SS; Reddy AM
J Chromatogr Sci; 2012 Oct; 50(9):745-55. PubMed ID: 22562819
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous determination of aliskiren hemifumarate, amlodipine besylate, and hydrochlorothiazide in their triple mixture dosage form by capillary zone electrophoresis.
Salim MM; Ebeid WM; El-Enany N; Belal F; Walash M; Patonay G
J Sep Sci; 2014 May; 37(9-10):1206-13. PubMed ID: 24574149
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous determination of amlodipine and aliskren in tablets by high-performance liquid chromatography.
Özdemir FA; Akyüz A
J Chromatogr Sci; 2014 Aug; 52(7):685-90. PubMed ID: 23839804
[TBL] [Abstract][Full Text] [Related]
17. Stability-indicating LC method for the simultaneous determination of lisinopril and hydrochlorothiazide.
de Diego M; Soto J; Mennickent S
J Chromatogr Sci; 2014; 52(10):1193-7. PubMed ID: 24297524
[TBL] [Abstract][Full Text] [Related]
18. Estimation of Amlodipine Besylate, Valsartan and Hydrochlorothiazide in Bulk Mixture and Tablet by UV Spectrophotometry.
Galande VR; Baheti KG; Indraksha S; Dehghan MH
Indian J Pharm Sci; 2012 Jan; 74(1):18-23. PubMed ID: 23204617
[TBL] [Abstract][Full Text] [Related]
19. Stability-indicating UPLC method for determining related substances and degradants in dronedarone.
Pydimarry SP; Cholleti VK; Vangala RR
J Chromatogr Sci; 2014 Aug; 52(7):666-75. PubMed ID: 23863770
[TBL] [Abstract][Full Text] [Related]
20. A new stability-indicating HPLC-UV method for determination of amlodipine besylate and its impurities in drug substance.
Jeelani S; Kouznetsova N
Heliyon; 2023 Sep; 9(9):e19993. PubMed ID: 37809728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
